Free Radicals

Disease caused by a chronic free radical, which may take many years for the disease become apparent. Examples of diseases that are often associated with free radical is heart attacks,anti aging, cancer, cataracts and decreased kidney function. To prevent or reduce chronic diseases is necessary because free radicals antioxidants, glutathione.

Free radicals are molecules that lose electrons, so that the molecule becomes unstable and is always trying to take electrons from other molecules or cells. Free radicals can be generated from the metabolism of the body and external factors such as cigarette smoke, the result of ultraviolet radiation, chemical substances within the food and other pollutants.
Formation of free radicals within the body:
● At the time we breathe
(A byproduct of oxidation or combustion process)
● excessive Sports
● If there is inflammation
● Exposed Environmental pollution
(Smoke cigarettes, motor vehicles, radiation, etc.)
● etc.
At the time of infection, the radical needed to kill the microorganisms causing the infection. But excessive exposure to free radicals and continuously can cause cell damage, reduces the ability of cells to adapt to their environment, and can eventually cause cell death. Reactive free radicals, can cause cell damage, reduces the ability of adaptation to cell, that cell death causing disorder / disease.
With OXIS International, Inc. is engaged in the research, development and sale of products that counteract the harmful effects of “oxidative stress.” Advancing Oxidative Stress Technology Oxis International, Inc. (OTCBB: OXIS) is the premiere provider for the potent antioxidant, Ergothioneine and through their patented synthetic manufacturing process remains the only significant commercial source of pure l-ergothioneine worldwide.
We focus on naturally occurring protective substances since they are more likely to be both safe and efficacious. Our primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L-­Ergothioneine (“ERGO”), as a key component. We own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. Our patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process.Our site has information for people who are new to the stock trading world. Penny stocks are those companies with shares trading with Oxis. OXIS is now focusing its business on its rich science background and its related 12 key patents and 7 patent pending applications and other new research.